跳至主要内容
临床试验/NCT06450769
NCT06450769尚未招募不适用

Effect of Mediterranean Diet Supplemented With Aronia and Low-Fat Diet on Hepatic Steatosis, Inflammation, Oxidative Stress and Microbiota in Non-alcoholic Fatty Liver Disease

Istanbul Kent University0 个研究点目标入组 54 人开始时间: 2024年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
54
主要终点
Oxidative stress

研究概览

简要总结

Adults newly diagnosed with NAFLD will be included in the study. At the beginning of the research, the socio-demographic characteristics and nutritional habits of the individuals will be questioned with a face-to-face questionnaire. In addition, at the beginning of the study, blood samples, 3-day food consumption record, physical activity record, anthropometric measurements (height, body weight, waist, hip and neck circumference and body composition analysis) and stool samples will be taken from the patients. Oxidative stress (TAS, TOS, SOD, Malondialdehyde, Catalase, Glutathione peroxidase, Glutathione, AGE and DNA oxidative damage) and inflammation (CRP, TNF-alpha, IL-17, IL-23, IL-10, IL-13, TGF-beta) parameters in blood samples will be analyzed. Patients will then be randomized into four groups to follow a Mediterranean diet supplemented with aronia, a Mediterranean diet, a low-fat diet supplemented with aronia, or a low-fat diet. Necessary training will be given to the participants so that they can apply the individually planned diet. Dietary adherence and anthropometric measurements will be evaluated every 2 weeks. At the end of the twelve-week follow-up, all parameters evaluated at the beginning of the study will be repeated and compared with previous values.

详细描述

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease in which more than 5% fat accumulation in the liver (steatosis). It has become the most common liver disease in adults with the effect of obesity. In fact, NAFLD is seen in approximately 25% of adults. If left untreated, it can progress to cirrhosis, hepatocellular carcinoma, and end-stage liver failure. It is obvious that it is necessary to identify preventive factors for NAFLD and to develop new approaches for its treatment. There is an increase in inflammation and oxidative stress levels in NAFLD, which is important for the development of possible treatment methods. In this study, the Mediterranean diet supplemented with aronia is expected to contribute positively to progression of the disease by improving inflammation and oxidative stress parameters. Adding aronia to the Mediterranean diet will increase the polyphenol content of this diet. This study was planned with the thought that a Mediterranean diet supplemented with aronia will have positive effects on hepatic steatosis, oxidative stress, inflammation, and microbiota in NAFLD, where lifestyle changes, including healthy nutrition, are included in the primary treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18- 64 years of age
  • Body mass index (BMI) 25-40 kg/m2
  • Newly diagnosed with NAFLD and has not been treated before
  • Volunteering

排除标准

  • Chronic disease other than NAFLD
  • Pregnancy or breastfeeding
  • Bleeding disorder
  • Regular medication use
  • Any food allergies or intolerances
  • Being on a special diet treatment
  • Smoking in the last year
  • Alcohol use in the last year
  • Having used antibiotics in the last 3 months
  • Use of prebiotics or probiotics in the last 3 months
  • Use of proton pump inhibitors in the last 3 months
  • Use of vitamin-mineral supplementation in the last 3 months
  • Use of nutritional supplements in the last 3 months

结局指标

主要结局

Oxidative stress

时间窗: Baseline and end of the 12th week

TAS, TOS, SOD, Malondialdehyde (MDA), Catalase, Glutathione peroxidase, Glutathione, AGE and DNA oxidative damage will be evaluated.

Microbiota analysis

时间窗: Baseline and end of the 12th week

16s rRNA Gene Sequencing and Compositional Analyzes

Body composition analysis

时间窗: Baseline, every 15 days and end of the 12th week

Body weight, height and body composition, waist, hip and neck circumference measurements

Inflammation

时间窗: Baseline and end of the 12th week

CRP, TNF-alfa, IL-10, IL-13, IL-17, IL-23, TGF-β, LPS will be evaluated.

Degree of hepatic steatosis

时间窗: Baseline and end of the 12th week

Evaluation of hepatic steatosis by liver ultrasonography

次要结局

未报告次要终点

研究者

发起方
Istanbul Kent University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gamze Akbulut

Professor Doctor

Istanbul Kent University

相似试验

Aronia and Non-alcoholic Fatty Liver Disease | 临床试验